Abstract: Arabs represent 5% of the world population and have a high prevalence of common disease, yet remain greatly underrepresented in genome-wide association studies, where only 1 in 600 individuals are Arab. We highlight the persistent and unaddressed underrepresentation of Arabs in genomic databases and discuss its impact on public health genomics and missed opportunities for biological discovery.
Introduction
Modern genetics stands at a crossroads. While the field promises a future of precision medicine tailored to an individual's unique genetic makeup, this future is currently being built on a foundation that excludes a significant portion of the global population. A recent commentary published in Genome Medicine highlights a critical "blind spot": the massive underrepresentation of Arab populations in genomic research. Despite accounting for 5% of the world’s population, individuals of Arab descent are almost entirely absent from the datasets used to define genetic risk and discover new therapeutic targets.
The Genomic Diversity Gap
The "genomic diversity gap" is a well-documented phenomenon where the vast majority of genetic studies focus on individuals of European descent. However, the exclusion of Arab populations is particularly concerning due to the region's unique health profile. Arab populations face a high prevalence of common complex diseases, including cardiovascular disease, type 2 diabetes, and various cancers. Furthermore, unique cultural and demographic factors, such as high rates of consanguinity (marriage between relatives) and specific environmental factors like widespread vitamin D deficiency, create a distinct genetic landscape that remains largely unmapped.
Quantifying Representation Trends
To quantify this disparity, researchers performed a comprehensive meta-analysis of the GWAS Catalog, tracking global participation trends from 2006 to 2022. The results reveal a stark reality: only approximately 0.17% of individuals in the GWAS Catalog are of Arab ancestry. In contrast, 523 out of every 600 individuals in these studies are of European descent. This means that for every Arab individual studied, over 500 Europeans are represented.
As shown in Figure 1, Arab representation has remained stagnant near 0% for nearly two decades. The only significant recent uptick is attributable to a single source: the Qatar Biobank (QBB). While the QBB is a landmark achievement, it also highlights the total absence of data from other major Arab nations such as Iraq, Syria, Algeria, and Libya.
Functional Impact: The MAF Gap and Clinical Inaccuracy
This lack of representation is not merely a statistical oversight; it has direct consequences for clinical care. One of the primary tools in genomic medicine is the Polygenic Risk Score (PRS), which predicts an individual's risk for a disease based on thousands of genetic variants. Because these scores are trained primarily on European data, their accuracy plummets when applied to non-European populations.
A key driver of this inaccuracy is the difference in Minor Allele Frequency (MAF)—the frequency of the less common version of a gene. The researchers found that the frequency of disease-causing variants is, on average, 7.6% lower in Arabs than in Europeans. This statistical divergence ensures that genetic risk models developed in the West are fundamentally ill-equipped for the Middle East, potentially leading to "healthcare disparity by design."
Missed Opportunities for Biological Discovery
Beyond clinical risk prediction, the exclusion of Arab genomes represents a massive missed opportunity for global science. High levels of consanguinity in certain regions lead to "autozygosity," which allows for the identification of "human knockouts"—individuals who naturally lack both functional copies of a specific gene. Studying these rare individuals can reveal the exact function of a gene, potentially identifying new drug targets that could benefit the entire global population. The initial GWAS from the Qatar Biobank alone identified 24.6 million previously unknown genetic variants, illustrating the vast biological diversity currently hidden from view.
Addressing Administrative Erasure
A significant hurdle to progress is the administrative categorization of Arabs in Western research. In many datasets and the US Census, Arabs are categorized as "White." This administrative erasure makes it nearly impossible for researchers to disaggregate data and study the specific health needs of the Arab diaspora living in the West.
Conclusion and Future Directions
To close the genomic diversity gap, the authors suggest several critical steps:
- Policy Reform: Encouraging census and research bodies to recognize "Arab" as a distinct category to facilitate research in diaspora populations.
- Strategic Recruitment: Intentionally including Arab participants in global genomic initiatives to ensure equitable benefit from precision medicine.
- Infrastructure Investment: Supporting Arab nations in developing their own biobanks and training local scientists to manage their genomic resources.
Without these changes, the promise of genomic medicine will remain a privilege of the few, rather than a benefit for all.
Summary updated